학술논문

Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients.
Document Type
Article
Source
Leukemia (08876924). Apr2014, Vol. 28 Issue 4, p967-970. 4p. 1 Diagram, 1 Graph.
Subject
*CYTARABINE
*MYELOID leukemia
*PATIENTS
Language
ISSN
0887-6924
Abstract
A letter to the editor is presented on lenalidomide plus cytarabine induce which induced remission that can be predicted by genetic profiling in older people with acute myeloid leukemia.